Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix

Cancer Research

Volumn 64, Issue 16, 2004, Pages 5876-5881

  Mayer, Arnulf ^a   Wree, Alexander ^a   Höckel, Michael ^b   Leo, Cornelia ^b   Pilch, Henryk ^a   Vaupel, Peter ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CELL AGGREGATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MAJOR CLINICAL STUDY; OXYGEN TENSION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA; TISSUE NECROSIS; TISSUE OXYGENATION; TUMOR CELL; UTERINE CERVIX CARCINOMA; UTERUS BIOPSY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL NUCLEUS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MIDDLE AGED; NEOPLASM STAGING; OXYGEN; PARTIAL PRESSURE; TRANSCRIPTION FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 4143118037     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3566     Document Type: Article

References (23)

1. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989;49(23):6449-65.
2. Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst (Bethesda) 2001;93(4):266-76.
3. Höckel M, Schlenger K, Aral B, Mitze M, Schäffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56(19):4509-15.
4. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, Gassmann M. Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J 2001;15(7):1312-4.
5. Maxwell PH, Ratcliffe PJ. Oxygen sensors and angiogenesis. Semin Cell Dev Biol 2002;13(1):29-37.
6. Giaccia A, Siim BG, Johnson RS. HIF-1 as a target for drug development. Nat Rev Drug Discov 2003;2(10):803-11.
7. Bilton RL, Booker GW. The subtle side to hypoxia inducible factor (HIFα) regulation. Eur J Biochem 2003;270(5):791-8.
8. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3(10):b1721-32.
9. 2 tension measurements. Cancer Res 1991;51(22):6098-102.
10. Birner P, Schindl M, Obermair A, Plank C, Breitenecker G, Oberhuber G. Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res 2000;60(17):4693-6.
11. Haugland HK, Vukovic V, Pintilie M, et al. Expression of hypoxia-inducible factor-1α in cervical carcinomas: correlation with tumor oxygenation. Int J Radiat Oncol Biol Phys 2002;53(4):854-61.
12. Aebersold DM, Burri P, Beer KT, et al. Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 2001;61(7):2911-6.
13. Janssen HL, Haustermans KM, Sprong D, et al. HIF-1A, pimonidazole, and iodode-oxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int J Radiat Oncol Biol Phys 2002;54(5):1537-49.
14. Zhong H, Mabjeesh N, Willard M, Simons J. Nuclear expression of hypoxia-inducible factor 1α protein is heterogeneous in human malignant cells under normoxic conditions. Cancer Lett 2002;181(2):233-8.
15. Chan DA, Sutphin PD, Denko NC, Giaccia AJ. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α. J Biol Chem 2002;277(42):40112-7.
16. Saramaki OR, Savinainen KJ, Nupponen NN, Bratt O, Visakorpi T. Amplification of hypoxia-inducible factor 1α gene in prostate cancer. Cancer Genet Cytogenet 2001;128(1):31-4.
17. Burri P, Djonov V, Aebersold DM, et al. Significant correlation of hypoxia-inducible factor-1α with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2003;56(2):494-501.
18. Schindl M, Schoppmann SF, Samonigg H, et al. Overexpression of hypoxia-inducible factor 1α is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 2002;8(6):1831-7.
19. Birner P, Gatterbauer B, Oberhuber G, et al. Expression of hypoxia-inducible factor-1α in oligodendrogliomas: its impact on prognosis and on neoangiogenesis. Cancer (Phila) 2001;92(1):165-71.
20. Beasley NJ, Leek R, Alam M, et al. Hypoxia-inducible factors HIF-1α and HIF-2α in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 2002;62(9):2493-7.
21. Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature (Lond) 1998;394(6692):485-90.
22. Ryan HE, Poloni M, McNulty W, et al. Hypoxia-inducible factor-1α is a positive factor in solid tumor growth. Cancer Res 2000;60(15):4010-5.
23. Blancher C, Moore JW, Talks KL, Houlbrook S, Harris AL. Relationship of hypoxia-inducible factor (HIF)-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 2000;60(24):7106-13.